← Open Payments lookup

LAKEESHA BROUGHTON-NELSON: Open Payments

NPI 1134855992 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,604 in 59 payments from 11 companies in 2025. Trend: 2023 $157 · 2024 $1,231 · 2025 $1,604

Food & beverage: $1,604
CompanyPaymentsAmount
Alkermes, Inc.10$342
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$233
Otsuka America Pharmaceutical, Inc.5$215
Axsome Therapeutics, Inc.4$196
Neurocrine BioSciences, Inc.9$191
ABBVIE INC.12$141
Lundbeck LLC6$123
Vanda Pharmaceuticals Inc.2$77
E.R. Squibb & Sons, L.L.C.2$43
Takeda Pharmaceuticals U.S.A., Inc.2$28

Products named: REXULTI, CAPLYTA, ARISTADA, Auvelity, INGREZZA, VRAYLAR, LYBALVI, FANAPT.

Industry payments across AL — which companies pay providers there.